The Ophthalmic devices Market in Europe was valued at USD 9.71 billion in 2019 and estimated to be growing at a CAGR of 6.24 %, to reach USD 13.14 billion by 2024 during the forecast period. Factors such as increasing older people population and technology advancements related to ophthalmology and increasing R & D activities are majorly propelling the market growth.
Ophthalmic devices are the technology-based devices that are used for the diagnosis of any defect in the human visual pathway. The leading cause of the error may be any eye-related infection, disorder or can be congenital. Many new developed and easy-to-use ophthalmic devices are helping the patients globally. The ophthalmic devices market is predicted to witness significant growth shortly owing to increased occurrence of eye-related disorders such as diabetic retinopathy, presbyopia, cataracts, macular degeneration, keratoconus and uveitis across the globe. Europe is expected to account for the second-largest share in the market due to increasing R&D investments for the development of new products.
The increasing geriatric population mainly drives Europe Ophthalmic devices market. As, aged people are more prone to developing eye-related disorders/conditions such as dry eye, glaucoma, promoting awareness about these disorders, continuous technological advancements in the field of medical technology for the development of novel products which have more efficacy and accuracy are boosting the market. The high cost of ophthalmic devices, the lack of skilled professionals in the rural regions of developing countries are limiting the growth of the market.
Europe ophthalmic devices market segmented and sub-segmented into the following categories.
Regionally, the UK ophthalmic devices market is the currently leading Europe market and estimated to retain its dominance during the forecast period. Increasing usage contact lens, standard growth in eye-related disorders and growing awareness among the people are majorly attributing the market growth in the UK.
Germany ophthalmic devices market is estimated to display a robust growth rate during the forecast period. Germany has well-established and developed healthcare system related to ophthalmic devices and spends massively on the R&D for pharmaceutical devices, which is majorly boosting the market growth.
France ophthalmic devices market is predicted to rise at a healthy rate owing to the increasing cataract volume, availability of new drugs and devices, population shift growing impact of eye-related disorders are the factors accelerating the growth of ophthalmic devices market.
Key Market players in Europe ophthalmic devices market include Alcon Inc., Essilor International S.A., Johnson & Johnson, Abbott Medical Optics Inc., Bausch & Lomb, Inc., Haag-Streit AG, Topcon Corporation, Carl Zeiss Meditec AG, Nidek Co. Ltd., and Ziemer Ophthalmic Systems AG
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product Type
5.1.1 Introduction
5.1.2 Surgical Devices
5.1.3 Monitoring and diagnostic devices
5.1.4 vision care
5.1.5 Y-o-Y Growth Analysis, By Product Type
5.1.6 Market Attractiveness Analysis, By Product Type
5.1.7 Market Share Analysis, By Product Type
5.2 Devices
5.2.1 Introduction
5.2.2 Lenses
5.2.3 Glaucoma surgical devices
5.2.4 Ophthalmic Lasers
5.2.5 Cataract surgical devices
5.2.6 Iris retractors
5.2.7 lens clearing and disinfectant solutions
5.2.8 Others
5.2.9 Y-o-Y Growth Analysis, By Devices
5.2.10 Market Attractiveness Analysis, By Devices
5.2.11 Market Share Analysis, By Devices
5.3 End-Users
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Eye care Clinics
5.3.4 Research Institutes
5.3.5 Others
5.3.6 Y-o-Y Growth Analysis, By End-users
5.3.7 Market Attractiveness Analysis, By End-users
5.3.8 Market Share Analysis, By End-users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product Type
6.1.3.3 By Devices
6.1.3.4 By End-users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product Type
6.1.4.3 By Devices
6.1.4.4 By End-users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product Type
6.1.5.3 By Devices
6.1.5.4 By End-users
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Alcon Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Essilor International S.A
8.3 Johnson & Johnson
8.4 Abbott Medical Optics Inc.
8.5 Bausch & Lomb, Inc.
8.6 Haag-Streit AG
8.7 Topcon Corporation
8.8 Carl Zeiss Meditec AG
8.9 Nidek Co. Ltd.
8.10 Ziemer Ophthalmic Systems AG
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
